Skip to content

Advertisement

Open Peer Review Reports for: Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Jul 2016 Submitted Original manuscript
8 Feb 2017 Reviewed Reviewer Report - Abhishek Garg
14 Feb 2017 Reviewed Reviewer Report - Shigetaka Shimodaira
18 Feb 2017 Reviewed Reviewer Report - Tuncay Göksel
24 Jul 2017 Author responded Author comments - Chunlei Ge
Resubmission - Version 2
24 Jul 2017 Submitted Manuscript version 2
28 Jul 2017 Reviewed Reviewer Report - Abhishek Garg
29 Nov 2017 Author responded Author comments - Chunlei Ge
Resubmission - Version 3
29 Nov 2017 Submitted Manuscript version 3
Publishing
29 Nov 2017 Editorially accepted
21 Dec 2017 Article published 10.1186/s12885-017-3859-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement